FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel 5-substituted pyrimidines of general formula (I), their pharmaceutically acceptable additive salts probably in form of their stereochemically isomeric form. In general formula (I), A represents -CH2-CH2-, -CH=CH-; each of R1 independently represents hydrogen; R2 represents cyano; X1 represents -NR1-; R3 represents H, C1-6-alkyl, halogen; R4 represents H, C1-6-alkyl, halogen; R5 represents nitro, amino, mono- and di(C1-4-alkyl)amino, phenyl, probably substituted by halogen, halogen, -CO-H-, -COOR7, -NH-C(=O)H, -NH-C(=O)R6, -CH=N-O-R8; R6 represents C1-4-alkyl, amino, mono- or di(C1-4-alkyl)amino or polyhalogen-C1-6-alkyl; R7represents hydrogen, C1-6-alkyl; R8 represents hydrogen, C1-6-alkyl. Invention also relates to pharmaceutical composition based on novel compounds.
EFFECT: elaborated are compounds which possess antiviral activity with respect to HIV infection.
7 cl, 2 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
HIV-INHIBITING 5-(HYDROXYMETHYLENE- AND AMINOMETHYLENE)SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2452737C2 |
HIV-INHIBITING 5-CARBO- OR HETEROCYCLIC SUBSTITUTED PYRIMIDINES | 2005 |
|
RU2403244C2 |
HIV-INHIBITING 2-(4-CYANOPHENYL)-6-HYDROXYLAMINO-PYRIMIDINES | 2006 |
|
RU2401261C2 |
HIV-INHIBITING BICYCLIC PYRIMIDIN DERIVATIVES | 2005 |
|
RU2403254C2 |
HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES | 2005 |
|
RU2405778C2 |
HIV INHIBITING DERIVATIVES OF 2-(4-CYANOPHENYLAMINO) PYRIMIDINE | 2006 |
|
RU2403245C2 |
HIV-INHIBITING 2-(4-CYANOPHENYLAMINO)-PYRIMIDINE-OXIDE DERIVATIVES | 2006 |
|
RU2398768C2 |
HIV-INHIBITING 5-AMIDO-SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2480464C2 |
1,2,4-TRIAZINE-6-ONE DERIVATIVES, INHIBITING HIV | 2005 |
|
RU2401833C2 |
DERIVATIVES OF 1,10b-DIHYDRO-2-(AMINOCARBONYLPHENYL)-5H-PYRAZOLO[1,5-c][1,3]BENZOXASIN-5-YL)PHENYLMETHYLMETHANON AS INHIBITORS OF HIV VIRUS REPLICATION | 2005 |
|
RU2382789C2 |
Authors
Dates
2011-01-27—Published
2005-09-29—Filed